Outcomes among patients with non‐ST‐elevation myocardial infarction on chronic anticoagulation: Insights from the National Inpatient Sample
- 27 August 2024
- journal article
- research article
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 104 (5) , 928-933
Abstract
Background: Chronic systemic anticoagulation use is prevalent for various thromboembolic conditions. Anticoagulation (usually through heparin products) is also recommended for the initial management of non‐ST‐elevation myocardial infarction (NSTEMI).Aims: To evaluate the in‐hospital outcomes of patients with NSTEMI who have been on chronic anticoagulation.Methods: Using the National Inpatient Sample (NIS) years 2016–2020, NSTEMI patients and patients with chronic anticoagulation were identified using the appropriate International Classification of Diseases, 10th version (ICD‐10) appropriate codes. The primary outcome was all‐cause in‐hospital mortality while the secondary outcomes included major bleeding, ischemic cerebrovascular accident (CVA), early percutaneous coronary intervention (PCI) (i.e., within 24 h of admission), coronary artery bypass graft (CABG) during hospitalization, length of stay (LOS), and total charges. Multivariate logistic or linear regression analyses were performed after adjusting for patient‐level and hospital‐level factors.Results: Among 2,251,914 adult patients with NSTEMI, 190,540 (8.5%) were on chronic anticoagulation. Chronic anticoagulation use was associated with a lower incidence of in‐hospital mortality (adjusted odds ratio [aOR]: 0.69, 95% confidence interval [CI]: 0.65−0.73, p < 0.001). There was no significant difference in major bleeding (aOR: 0.95, 95% CI: 0.88−1.0, p = 0.15) or ischemic CVA (aOR: 0.23, 95% CI: 0.03−1.69, p = 0.15). Chronic anticoagulation use was associated with a lower incidence of early PCI (aOR: 0.78, 95% CI: 0.76−0.80, p < 0.001) and CABG (aOR: 0.43, 95% CI: 0.41−0.45, p < 0.001). Chronic anticoagulation was also associated with decreased LOS and total charges (adjusted mean difference [aMD]: −0.8 days, 95% CI: −0.86 to −0.75, p < 0.001) and (aMD: $−19,340, 95% CI: −20,692 to −17,988, p < 0.001).Conclusions: Among patients admitted with NSTEMI, chronic anticoagulation use was associated with lower in‐hospital mortality, LOS, and total charges, with no difference in the incidence of major bleeding.Keywords
This publication has 14 references indexed in Scilit:
- 2023 ESC Guidelines for the management of acute coronary syndromesEuropean Heart Journal, 2023
- Ten-Year Trends in Patient Characteristics, Treatments, and Outcomes in Myocardial Infarction From National Cardiovascular Data Registry Chest Pain–MI RegistryCirculation: Cardiovascular Quality and Outcomes, 2022
- Antithrombotic Therapy for VTE DiseaseChest, 2021
- Is percutaneous coronary intervention safe during uninterrupted direct oral anticoagulant therapy in patients with atrial fibrillation and acute coronary syndromes?Open Heart, 2021
- Incidence, treatment, and outcomes of acute myocardial infarction following transcatheter or surgical aortic valve replacementCatheterization and Cardiovascular Interventions, 2021
- Systemic Sclerosis Is Associated With Increased Inpatient Mortality in Patients Admitted for Acute Coronary SyndromeJCR: Journal of Clinical Rheumatology, 2020
- Trends in Utilization and Safety of In-Hospital Coronary Artery Bypass Grafting During a Non-ST-Segment Elevation Myocardial InfarctionThe American Journal of Cardiology, 2020
- Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCIJACC, 2019
- 2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions: a joint consensus document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA)EP Europace, 2018
- Meta-analysis of uninterrupted as compared to interrupted oral anticoagulation with or without bridging in patients undergoing coronary angiography with or without percutaneous coronary interventionInternational Journal of Cardiology, 2016